Portland biotech Sparrow Pharmaceuticals raises $10M to further clinical trials

Sparrow Pharmaceuticals is developing, novel targeted therapies for disorders caused by excess corticosteroids.
Source: bizjournals.com Health Care:Pharmaceuticals headlines - Category: Pharmaceuticals Authors: Source Type: news